Literature DB >> 35217282

MRI appearance of BRCA-associated prostate cancer.

Omar Kamal1, Bryan R Foster1, Daniel J Young1, Donna E Hansel1, Fergus V Coakley2.   

Abstract

Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause of cancer related mortality in men. Prognosis is variable and dependent on several clinical and genetic factors, including BRCA gene mutations. Recent clinical studies have reported that BRCA-associated prostate cancer is a more aggressive subtype with a higher probability of nodal involvement and distant metastases at the time of diagnosis, but radiological findings have not been described. Accurate recognition of those tumors could help guide clinical management and prompt testing and counseling for BRCA mutations. We have recently encountered four patients with BRCA-associated prostate cancer who underwent multiparametric MRI. The MRI appearances of these tumors, which were generally locally advanced and aggressive in appearance, are presented to facilitate recognition of BRCA-associated prostate cancer and guide potential genetic testing and counseling.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRCA gene mutation; MRI; Prostate

Mesh:

Year:  2022        PMID: 35217282     DOI: 10.1016/j.clinimag.2022.02.007

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  1 in total

1.  An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.

Authors:  David Aebisher; Michał Osuchowski; Dorota Bartusik-Aebisher; Magdalena Krupka-Olek; Klaudia Dynarowicz; Aleksandra Kawczyk-Krupka
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.